18f-labeled peptide ligands useful in pet and cerenkov luminescene imaging
US-2025388523-A1 · Dec 25, 2025 · US
US9403875B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9403875-B2 |
| Application number | US-69512510-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jan 27, 2010 |
| Priority date | Jan 27, 2009 |
| Publication date | Aug 2, 2016 |
| Grant date | Aug 2, 2016 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Disclosed is a class of versatile Sarcophagine based bifunctional chelators (BFCs) containing a hexa-aza cage for labeling with metals having either imaging, therapeutic or contrast applications radiolabeling and one or more linkers (A) and (B). The compounds have the general formula where A is a functional group selected from group consisting of an amine, a carboxylic acid, an ester, a carbonyl, a thiol, an azide and an alkene, and B is a functional group selected from the group consisting of hydrogen, an amine, a carboxylic acid, and ester, a carbonyl, a thiol, an azide and an alkene. Also disclosed are conjugate of the BFC and a targeting moiety, which may be a peptide or antibody. Also disclosed are metal complexes of the BFC/targeting moiety conjugates that are useful as radiopharmaceuticals, imaging agents or contrast agents.
Opening claim text (preview).
We claim: 1. A chemical composition comprising: wherein A is a carboxylic acid having the formula: and wherein R 1 , R 2 , R 3 , and R 4 are independently selected from the group consisting of H, halogen, alkyl, alkoxy or alkene, and a salt or an ester thereof, and B is a functional group selected from the group consisting of hydrogen, and amine, a carboxylic acid, an ester, a carbonyl, a thiol, an azide and alkene. 2. The chemical composition according to claim 1 , wherein R 1 , R 2 , R 3 , and R 4 are hydrogen. 3. A chemical composition comprising a molecule selected from the group consisting of: and a salt or an ester thereof. 4. A radiopharmaceutical comprising a compound having the formula: 5. The radiopharmaceutical according to claim 4 , further comprising a carrier.
the peptide being a RGD-containing peptide · CPC title
conjugates with carriers being peptides, polyamino acids or proteins (antibodies A61K51/10) · CPC title
Ortho-condensed systems · CPC title
Bombesin; Related peptides (having more than 20 amino acids C07K14/57572) · CPC title
complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.